CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Evoked fields before and after a local block (Xylocaine)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00217243
NCT00217243N/ACompleted
CompareCT.gov

Evoked (Magnetic) Cortical Fields for the Comparative Study of Mechanisms Underlying Chronic Non-malignant Pain in Peripheral Nerve Injury (CRPS II) and CRPS I (Chronic Regional Pain Syndrome I)

Medical Center Alkmaar·observational·Posted Sep 22, 2005·Updated Sep 18, 2009

In Brief

An observational study evaluating Evoked fields before and after a local block (Xylocaine) for Complex Regional Pain Syndromes. Completed, enrolled 60 participants across 1 site.

Detailed Summary

In order to be able to study the effects of evoked fields with magnetoencephalography (MEG) in two groups of patients, comparison is made with a group of healthy volunteers.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsComplex Regional Pain Syndromes
CountriesNetherlands
CollaboratorsRudolf Magnus Institute - University of Utrecht, Technical University of Twente, VU University of Amsterdam, Dept. of Clinical Neurophysiology - VU University Hospital Amsterdam, Human Brain Mapping and Cortical Imaging Laboratory, Centre for Sensory - Motor Interaction,, Aalborg University

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 22, 2005
Enrollment StartJun 1, 2005
Study CompletionJun 1, 2007
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

Evoked fields before and after a local block (Xylocaine)other

MEG registration after electrical median and ulnar nerve stimulation in subjects and patients. In the patient group another MEG was performed after an anaesthetic block (1-2 ml Lidocaine 1%) at the site of the nerve injury producing a painfree state